Freestone D S, Kelly A, Ferris R, Simmons R L, Bowker C, Letley E, Bye C
J Hyg (Lond). 1980 Feb;84(1):17-28. doi: 10.1017/s0022172400026474.
Nineteen (22.9%) of 83 sera collected before vaccination from adult volunteers aged 21-64 years were without neutralizing antibody to poliomyelitis at levels of 0.15 i.u./ml for types I and II and 0.1 i.u./ml for type III. Some correlations were found between the history of previous vaccination and the presence of antibody but these were not well defined. Vaccination with a single dose of trivalent oral polio vaccine elicited fourfold or greater antibody responses to one or more poliomyelitis types in 53 (63.9%) volunteers, the percentage antibody resposnes being inversely related to the titre of antibody present before vaccination. Types I, II or III poliomyelitis virus were recovered from 76.8% of faecal samples collected 1 week after vaccination. The percentage recovery progressively declined thereafter until virus was recovered from 10.5% of samples collected 6 weeks after vaccination. Type for type, the titres and percentages of antibody responses and virus shedding in faeces were similar following trivalent oral poliomyelitis vaccines whether prepared in monkey or human diploid cell substrates. Some change in reproductive capacity temperature (r.c.t./40) marker was found in faecal isolates from volunteers vaccinated with monkey kidney and human diploid grown vaccines but no change in 'd' marker was found.
在21至64岁成年志愿者接种疫苗前采集的83份血清中,有19份(22.9%)对脊髓灰质炎的中和抗体水平低于I型和II型0.15国际单位/毫升、III型0.1国际单位/毫升。既往接种史与抗体存在之间存在一些相关性,但并不明确。单剂量口服三价脊髓灰质炎疫苗接种后,53名(63.9%)志愿者对一种或多种脊髓灰质炎病毒型产生了四倍或更高的抗体反应,抗体反应百分比与接种前存在的抗体滴度呈负相关。接种疫苗1周后采集的粪便样本中,76.8%检出I型、II型或III型脊髓灰质炎病毒。此后病毒检出率逐渐下降,至接种疫苗6周后采集的样本中,病毒检出率降至10.5%。无论三价口服脊髓灰质炎疫苗是在猴肾细胞还是人二倍体细胞基质中制备,粪便中抗体反应滴度和百分比以及病毒排出情况在各型间相似。接种猴肾细胞培养疫苗和人二倍体细胞培养疫苗的志愿者粪便分离株中,生殖能力温度(r.c.t./40)标记有一些变化,但“d”标记无变化。